Gabriele Niedermann

6.6k citations

81 papers · 4.7k indexed · 1 hit paper · h-index 34

Immunology top 1%
- Immunotherapy and Immune Responses 25
- Immune Cell Function and Interaction 10
Oncology top 1%
- Cancer Immunotherapy and Biomarkers 21
- CAR-T cell therapy research 12
- Cancer Cells and Metastasis 10
- Peptidase Inhibition and Analysis 8
Cancer Research top 5%
Virology top 5%
Molecular Biology top 5%
- Ubiquitin and proteasome pathways 10
Genetics
- Glioma Diagnosis and Treatment 6

Co-authors: Elke Firat Simone Gaedicke Peter Van Endert Klaus Eichmann Fiona Hegi‐Johnson Shankar Siva Anne W.M. Lee N.G. Burnet
Cited by: Immunology Oncology Cancer Research
Journals: Science (2 papers)Proceedings of the National Academy of Sciences (4 papers)Nature Communications (1 paper)
Partner nations: Germany United States China

In The Last Decade

Gabriele Niedermann

79 papers receiving 4.6k citations

Hit Papers

align trajectories log scale

Peers

Countries citing papers authored by Gabriele Niedermann

Since Specialization

Citations

This map shows the geographic impact of Gabriele Niedermann's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gabriele Niedermann with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gabriele Niedermann more than expected).

Fields of papers citing papers by Gabriele Niedermann

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gabriele Niedermann. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gabriele Niedermann. The network helps show where Gabriele Niedermann may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Gabriele Niedermann, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Gabriele Niedermann Line = papers co-authored together Gabriele Niedermann links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Evaluating the efficacy and immunological impact of combined ICIs and SBRT in HCC: A narrative literature review Clinical and Translational Radiation Oncology ·Lara Caglayan,Oliver Blanck,Judit Boda-Heggemann,Thomas Brunner,Cas Stefaan Dejonckheere,Dan G. Duda,Elke Firat,Maria Hawkins,Julian Philipp Layer,Leitzen Christina,Alejandra Mendez-Romero,Gabriele Niedermann,Younèss Nour,Falk Röder,Gustavo Renato Sarria,Davide Scafa,Marta Scorsetti,Wiegreffe Shari,Anca-L. Grosu,Eleni Gkika	2026	0
2	Adding a PPARα Agonist Enhances T Cell-Mediated Effects of RT in Combination with Anti-PD-1 International Journal of Radiation OncologyBiologyPhysics ·Min Wang,Xi Rao,Simone Gaedicke,Lei Wang,Beatrice Menz,Gabriele Multhoff,Gabriele Niedermann	2024	1
3	Development of pharmacological immunoregulatory anti-cancer therapeutics: current mechanistic studies and clinical opportunities Signal Transduction and Targeted Therapy ·Nanhao Yin,Xintong Li,Xuanwei Zhang,Shaolong Xue,Yu Cao,Gabriele Niedermann,You Lu,Jianxin Xue	2024	37
4	Exploring the role of combined external beam radiotherapy and targeted radioligand therapy with [¹⁷⁷Lu]Lu-PSMA-617 for prostate cancer - from bench to bedside Theranostics ·D. Arbuznikova,A. Klotsotyra,Lisa Uhlmann,Lisa-Charlotte Domogalla,Nils Steinacker,Michael Mix,Gabriele Niedermann,Simon K. B. Spohn,Martin T. Freitag,Anca-Ligia Grosu,Philipp T. Meyer,Christian Gratzke,Matthias Eder,Constantinos Zamboglou,Ann-Christin Eder	2024	6
5	Hypofractionated radiotherapy combined with lenalidomide improves systemic antitumor activity in mouse solid tumor models Theranostics ·Kateryna Onyshchenko,Ren Luo,Xi Rao,Xuanwei Zhang,Simone Gaedicke,Anca-Ligia Grosu,Elke Firat,Gabriele Niedermann	2024	8
6	Systemic immune modulation by stereotactic radiotherapy in early-stage lung cancer npj Precision Oncology ·Eleni Gkika,Elke Firat,Sonja Adebahr,Erika Graf,Ilinca Popp,Gianluca Radicioni,Simon S. Lo,Ursula Nestle,Nils H. Nicolay,Gabriele Niedermann,Dan G. Duda,Anca‐L. Grosu	2023	12
7	Radiotherapy to reinvigorate immunotherapy activity after acquired resistance in metastatic non-small-cell lung cancer: A pooled analysis of two institutions prospective phase II single arm trials Radiotherapy and Oncology ·Ilinca Popp,Rianne D.W. Vaes,Lotte Wieten,Sonja Adebahr,Lizza Hendriks,Elham Bavafaye Haghighi,Juliette Degens,Henning Schäfer,Christine Greil,Stéphanie Peeters,Cornelius F. Waller,Ruud Houben,Gabriele Niedermann,Justyna Rawluk,Eleni Gkika,Justus Duyster,Anca-Ligia Grosu,Dirk De Ruysscher	2023	7
8	Necroptosis-dependent Immunogenicity of Cisplatin: Implications for Enhancing the Radiation-induced Abscopal Effect Clinical Cancer Research ·Ren Luo,Kateryna Onyshchenko,Liqun Wang,Simone Gaedicke,Anca-Ligia Grosu,Elke Firat,Gabriele Niedermann	2022	30
9	Immune cell infiltration pattern in non-small cell lung cancer PDX models is a model immanent feature and correlates with a distinct molecular and phenotypic make-up Journal for ImmunoTherapy of Cancer ·Eva Oswald,Daniel Bug,Anne Grote,Kanstantsin Lashuk,Nassim Bouteldja,Dorothée Lenhard,Anne Löhr,Anke Behnke,Volker Knauff,Anna Edinger,Kerstin Klingner,Simone Gaedicke,Gabriele Niedermann,Dorit Merhof,Friedrich Feuerhake,Julia Schueler	2022	10
10	Changes in Blood Biomarkers of Angiogenesis and Immune Modulation after Radiation Therapy and Their Association with Outcomes in Thoracic Malignancies Cancers ·Eleni Gkika,Sonja Adebahr,Anton Brenner,Tanja Schimek‐Jasch,Gianluca Radicioni,Jan-Philipp Exner,Alexander Rühle,Simon K. B. Spohn,Ilinca Popp,Constantinos Zamboglou,Tanja Sprave,Elke Firat,Gabriele Niedermann,Nils H. Nicolay,Ursula Nestle,Anca-Ligia Grosu,Dan G. Duda	2021	6
11	Cisplatin Facilitates Radiation-Induced Abscopal Effects in Conjunction with PD-1 Checkpoint Blockade Through CXCR3/CXCL10-Mediated T-cell Recruitment Clinical Cancer Research ·Ren Luo,Elke Firat,Simone Gaedicke,Elena Guffart,Tsubasa Watanabe,Gabriele Niedermann	2019	60
12	Adding Indoximod to Hypofractionated Radiotherapy with Anti-PD-1 Checkpoint Blockade Enhances Early NK and CD8+ T-Cell–Dependent Tumor Activity Clinical Cancer Research ·Tsubasa Watanabe,Simone Gaedicke,Elena Guffart,Elke Firat,Gabriele Niedermann	2019	20
13	Nucleofection with Plasmid DNA for CRISPR/Cas9-Mediated Inactivation of Programmed Cell Death Protein 1 in CD133-Specific CAR T Cells Human Gene Therapy ·Bian Hu,Yan Zou,Linlin Zhang,Jiaxing Tang,Gabriele Niedermann,Elke Firat,Xingxu Huang,Xuekai Zhu	2018	104
14	Checkpoint Antibodies but not T Cell–Recruiting Diabodies Effectively Synergize with TIL-Inducing γ-Irradiation Cancer Research ·Michael Hettich,Jayashree Lahoti,Shruthi Prasad,Gabriele Niedermann	2016	59
15	Early-onset Evans syndrome, immunodeficiency, and premature immunosenescence associated with tripeptidyl-peptidase II deficiency Blood ·Polina Stepensky,Anne Rensing‐Ehl,Ruth Gather,Shoshana Revel‐Vilk,Ute Fischer,Schafiq Nabhani,Fabian Beier,Tim H. Brümmendorf,Sebastian Fuchs,Simon Zenke,Elke Firat,Vered Molho Pessach,Arndt Borkhardt,Mirzokhid Rakhmanov,Bärbel Keller,Klaus Warnatz,Hermann Eibel,Gabriele Niedermann,Orly Elpeleg,Stephan Ehl	2014	57
16	FET-PET-based reirradiation and chloroquine in patients with recurrent glioblastoma Strahlentherapie und Onkologie ·Angelika Bilger,Martin-Immanuel Bittner,Anca‐L. Grosu,Nicole Wiedenmann,Philipp T. Meyer,Elke Firat,Gabriele Niedermann,Wolfgang Weber,D. Milanović	2014	24
17	Tripeptidyl Peptidase II Plays a Role in the Radiation Response of Selected Primary Cell Types but not Based on Nuclear Translocation and p53 Stabilization Cancer Research ·Elke Firat,Chizuko Tsurumi,Simone Gaedicke,Jisen Huai,Gabriele Niedermann	2009	14
18	Analysis of Direct and Cross-Presentation of Antigens in TPPII Knockout Mice1 The Journal of Immunology ·Elke Firat,Jisen Huai,Loredana Saveanu,Simone Gaedicke,Peter Aichele,Klaus Eichmann,Peter Van Endert,Gabriele Niedermann	2007	33
19	Ex Vivo Characterization of Multiepitopic Tumor-Specific CD8 T Cells in Patients with Chronic Myeloid Leukemia: Implications for Vaccine Development and Adoptive Cellular Immunotherapy The Journal of Immunology ·Monique Gannagé,Michał Abel,Anne-Sophie Michallet,Stéphanie Delluc,Marion Lambert,Stéphane Giraudier,Roland Kratzer,Gabriele Niedermann,Loredana Saveanu,François Guilhot,Luc Camoin,Bruno Varet,Agnès Buzyn,Sophie Caillat‐Zucman	2005	83
20	Efficient MHC Class I-Independent Amino-Terminal Trimming of Epitope Precursor Peptides in the Endoplasmic Reticulum Immunity ·Doriana Fruci,Gabriele Niedermann,Richard H. Butler,Peter Van Endert	2001	68

About Gabriele Niedermann

Gabriele Niedermann is a scholar working on Oncology, Immunology and Virology, having authored 81 papers that have together received 4.7k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (25 papers), Cancer Immunotherapy and Biomarkers (21 papers), CAR-T cell therapy research (12 papers), Cancer Cells and Metastasis (10 papers), Ubiquitin and proteasome pathways (10 papers), Immune Cell Function and Interaction (10 papers), Peptidase Inhibition and Analysis (8 papers) and Glioma Diagnosis and Treatment (6 papers). The work is most often cited by research in Immunology (1.6k citations), Oncology (1.9k citations) and Cancer Research (545 citations). Gabriele Niedermann has collaborated with scholars based in Germany, United States and China. Frequent co-authors include Elke Firat, Simone Gaedicke, Peter Van Endert, Klaus Eichmann, Fiona Hegi‐Johnson, Shankar Siva, Anne W.M. Lee, N.G. Burnet, Dirk De Ruysscher and Anca-Ligia Grosu. Their work appears in journals such as Science, Proceedings of the National Academy of Sciences and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact